Stocks in the News – ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), Interpace Diagnostics Group Inc (NASDAQ:IDXG)
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) traded at a yearly high level of $10.60 during the last trading session. The last session’s volume of 9.45 million shares waslower than its average volume of 157,311 shares. The company has its outstanding shares of 3.46 million. The stock, after opening at $2.11, closed at $2.12 by scoring 24.71%.
This stock is ahead of its 52-week low with +165.00%. Its last month’s stock price volatility remained 48.35% which for the week stands at 20.85%. The share price has moved forward from its 20 days moving average 118.60% and positively from its 50 days moving average 60.49%. The stock inclined 89.29% last month and is up 3.41 this year.
Interpace Diagnostics Group Inc (NASDAQ:IDXG) stock reached a 1-year peak price of $19.80. The stock has lost -6.03%, reaching at $0.904 after hovering between $0.90 and $1.01.
This stock is ahead of its 52-week low with +29.29%. Its last month’s stock price volatility remained 8.62% which for the week stands at 11.16%. The stock showed weekly upbeat performance of 0.49%, which was maintained for the month at -52.62%. Likewise, the negative performance for the quarter was recorded as -59.23% and for the year was -73.69%, while the YTD performance remained at -79.43%.
The relative strength index (RSI) is a technical indicator used in the analysis of financial markets. It is intended to chart the current and historical strength or weakness of a stock or market based on the closing prices of a recent trading period. The indicator should not be confused with relative strength.
The RSI is classified as a momentum oscillator, measuring the velocity and magnitude of directional price movements. Momentum is the rate of the rise or fall in price. The RSI computes momentum as the ratio of higher closes to lower closes: stocks which have had more or stronger positive changes have a higher RSI than stocks which have had more or stronger negative changes.
The RSI is most typically used on a 14-day timeframe, measured on a scale from 0 to 100, with high and low levels marked at 70 and 30, respectively. Shorter or longer timeframes are used for alternately shorter or longer outlooks. More extreme high and low levels—80 and 20, or 90 and 10—occur less frequently but indicate stronger momentum. After a recent check, Interpace Diagnostics Group Inc (NASDAQ:IDXG)’s 14-day RSI is presently at 30.08.